These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24834953)

  • 21. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diseases caused by human papillomavirus -- the possibilities and the public health advantages of prevention].
    Acs N; Bata Z; Danko D; Hernádi Z; Kálmán M; Kornya L; Kovács J; Mézáros G; Molnár MP; Mór Z; Novák Z; Sobel G; Szentirmay Z; Takács L; Tisza T
    Orv Hetil; 2012 Dec; 153 Suppl():3-38. PubMed ID: 23687666
    [No Abstract]   [Full Text] [Related]  

  • 23. Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
    American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care, American College of Obstetricians and Gynecologists' Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group
    Obstet Gynecol; 2020 Aug; 136(2):e15-e21. PubMed ID: 32732766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of human papillomavirus vaccination.
    Brotherton JM; Ogilvie GS
    Curr Opin Oncol; 2015 Sep; 27(5):399-404. PubMed ID: 26258273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA; Barley J
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
    Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
    BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications and efficacy of the human papillomavirus vaccine.
    Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
    Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages.
    Videla S; Darwich L; Cañadas M; Clotet B; Sirera G
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):947-57. PubMed ID: 24865412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV-positive head and neck cancers: a review of the literature.
    Minassian M
    J Dent Hyg; 2014 Aug; 88(4):194-201. PubMed ID: 25295840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
    Kiellberg Larsen H; Kofoed K; Sand C
    Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males.
    Goldstone SE; Jessen H; Palefsky JM; Giuliano AR; Moreira ED; Vardas E; Aranda C; Hillman RJ; Ferris DG; Coutlee F; Marshall JB; Vuocolo S; Haupt RM; Guris D; Garner E
    Vaccine; 2013 Aug; 31(37):3849-55. PubMed ID: 23831322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G
    Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum and clinical sequelae of human papillomavirus infection.
    Monk BJ; Tewari KS
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S6-13. PubMed ID: 18499914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
    de Sanjosé S; Bruni L; Alemany L
    Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine.
    Schlecht NF; Masika M; Diaz A; Nucci-Sack A; Salandy A; Pickering S; Strickler HD; Shankar V; Burk RD
    JAMA Netw Open; 2019 Oct; 2(10):e1914031. PubMed ID: 31651968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus (HPV): making the case for 'Immunisation for All'.
    Prue G; Lawler M; Baker P; Warnakulasuriya S
    Oral Dis; 2017 Sep; 23(6):726-730. PubMed ID: 27492979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy.
    Loverro G; Di Naro E; Caringella AM; De Robertis AL; Loconsole D; Chironna M
    Sex Transm Infect; 2016 Feb; 92(1):67-9. PubMed ID: 26203116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.